CDKN2A and acute lymphoblastic leukemia: Currently, there is still variability in the prognosis of pediatric ALL patients related to the CDKN2A/B, which may be due to the deletion of the CDKN2A/B being associated with specific genetics, with the frequency of CDKN2A/B deletion varying significantly depending on combination of other genes [22].